Expanded eligibility for emerging therapies in sickle cell disease in the UK – crizanlizumab and voxelotor

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 197; no. 4; pp. 502 - 504
Main Authors Vora, Sona M., Boyd, Stephen, Denny, Nicholas, Jackson, Elizabeth, Roy, Noemi B. A., Howard, Jo, Lugthart, Sanne
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2022
Subjects
Anemia, Sickle Cell - drug therapy
Antibodies, Monoclonal, Humanized
Benzaldehydes
Hematology
Humans
Pyrazines
Pyrazoles
Sickle cell anemia
Sickle cell disease
United Kingdom - epidemiology
United Kingdom
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.18059